{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:50:31Z","timestamp":1787701831086,"version":"build-2784847793"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Dedicator for cytokinesis 4 (DOCK4) is a guanine nucleotide exchange\nfactor (GEF) for the small GTPase Rac1. However, the functions of DOCK4 concerning the tumor\nmicroenvironment (TME) in colon adenocarcinoma (COAD) remain uncertain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The TIMER and GEPIA databases were used to analyze the DOCK4 expression between\nCOAD tissues and adjunct normal tissues. The PrognoScan database was used to assess the prognosis\nof DOCK4 expression in COAD. The co-expression networks of DOCK4 in COAD were\nconstructed by the LinkedOmics website. Furthermore, the correlation between DOCK4 expression\nand TME of COAD was explored using TIMER and TISIDB databases. Finally, the clone formation\nassay was used to further verify the function of DOCK4 in COAD. The Western blotting\nassay was used to confirm the mechanism related to DOCK4 in COAD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The DOCK4 expression was different significantly in COAD tissues and paracancerous\ntissues. The DOCK4 was found to play a poor role in the prognosis of patients with COAD. The\nDOCK4 was found to participate in the TME by promoting immune evasion of COAD. The reduction\nof DOCK4 expression inhibited the clone formation and Ras-associated protein 1A (Rap1A)\nexpression of HCT116 cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>DOCK4 potentially plays an important role in the regulation of TME in COAD.\nDOCK4 facilitates the development through the Rap1A pathway, thus becoming a novel prognostic\nbiomarker in COAD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207326666230912094101","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T10:39:53Z","timestamp":1694601593000},"page":"1119-1130","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["DOCK4 is a Novel Prognostic Biomarker and Correlated with Immune\nInfiltrates in Colon Adenocarcinoma"],"prefix":"10.2174","volume":"27","author":[{"given":"Xingjiang","family":"Xie","sequence":"first","affiliation":[{"name":"Department of General Surgery, Wenjiang District People\u2019s Hospital of Chengdu, Chengdu, Sichuan, 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology\uff0c Suining Central Hospital, Suining, Sichuan, 629000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Wenjiang District People\u2019s Hospital of Chengdu, Chengdu, Sichuan, 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Wenjiang District People\u2019s Hospital of Chengdu, Chengdu, Sichuan, 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Wenjiang District People\u2019s Hospital of Chengdu, Chengdu, Sichuan, 611130, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2019. CA Cancer J Clin  2019,69(1),7-34","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/annonc\/mdt157","volume":"24","author":"Garborg K.","year":"2013","unstructured":"Garborg K.; Holme \u00d8.; L\u00f8berg M.; Kalager M.; Adami H.O.; Bretthauer M.; Current status of screening for colorectal cancer. Ann Oncol  2013,24(8),1963-1972","journal-title":"Ann Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/cncr.24760","volume":"116","author":"Edwards B.K.","year":"2010","unstructured":"Edwards B.K.; Ward E.; Kohler B.A.; Eheman C.; Zauber A.G.; Anderson R.N.; Jemal A.; Schymura M.J.; Lansdorp-Vogelaar I.; Seeff L.C.; van Ballegooijen M.; Goede S.L.; Ries L.A.G.; Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer  2010,116(3),544-573","journal-title":"Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"Calon A.","year":"2012","unstructured":"Calon A.; Espinet E.; Palomo-Ponce S.; Tauriello D.V.F.; Iglesias M.; C\u00e9spedes M.V.; Sevillano M.; Nadal C.; Jung P.; Zhang X.H.F.; Byrom D.; Riera A.; Rossell D.; Mangues R.; Massagu\u00e9 J.; Sancho E.; Batlle E.; Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation. Cancer Cell  2012,22(5),571-584","journal-title":"Cancer Cell"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"Picard E.","year":"2020","unstructured":"Picard E.; Verschoor C.P.; Ma G.W.; Pawelec G.; Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front Immunol  2020,11,369","journal-title":"Front Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.prp.2015.05.010","volume":"211","author":"Cao H.","year":"2015","unstructured":"Cao H.; Xu E.; Liu H.; Wan L.; Lai M.; Epithelial\u2013mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract  2015,211(8),557-569","journal-title":"Pathol Res Pract"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1002\/ctm2.595","volume":"11","author":"Dou R.","year":"2021","unstructured":"Dou R.; Liu K.; Yang C.; Zheng J.; Shi D.; Lin X.; Wei C.; Zhang C.; Fang Y.; Huang S.; Song J.; Wang S.; Xiong B.; EMT\u2010cancer cells\u2010derived exosomal miR\u201027b\u20103p promotes circulating tumour cells\u2010mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med  2021,11(12),e595","journal-title":"Clin Transl Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2020.01.052","volume":"242","author":"Wang H.","year":"2020","unstructured":"Wang H.; Liu J.; Li J.; Zang D.; Wang X.; Chen Y.; Gu T.; Su W.; Song N.; Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Cancer Genet  2020,242,1-7","journal-title":"Cancer Genet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"Jiang X.","year":"2019","unstructured":"Jiang X.; Wang J.; Deng X.; Xiong F.; Ge J.; Xiang B.; Wu X.; Ma J.; Zhou M.; Li X.; Li Y.; Li G.; Xiong W.; Guo C.; Zeng Z.; Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer  2019,18(1),10","journal-title":"Mol Cancer"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"Quail D.F.","year":"2013","unstructured":"Quail D.F.; Joyce J.A.; Microenvironmental regulation of tumor progression and metastasis. Nat Med  2013,19(11),1423-1437","journal-title":"Nat Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e1069937","DOI":"10.1080\/2162402X.2015.1069937","volume":"5","author":"Maker A.V.","year":"2016","unstructured":"Maker A.V.; Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment\u2014Evidence to turn on the LIGHT. OncoImmunology  2016,5(1),e1069937","journal-title":"OncoImmunology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"769685","DOI":"10.3389\/fimmu.2021.769685","volume":"12","author":"Qiu C.","year":"2021","unstructured":"Qiu C.; Shi W.; Wu H.; Zou S.; Li J.; Wang D.; Liu G.; Song Z.; Xu X.; Hu J.; Geng H.; Identification of molecular subtypes and a prognostic signature based on inflammation-related genes in colon adenocarcinoma. Front Immunol  2021,12,769685","journal-title":"Front Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1245\/s10434-012-2668-9","volume":"20","author":"Katz S.C.","year":"2013","unstructured":"Katz S.C.; Bamboat Z.M.; Maker A.V.; Shia J.; Pillarisetty V.G.; Yopp A.C.; Hedvat C.V.; Gonen M.; Jarnagin W.R.; Fong Y.; D\u2019Angelica M.I.; DeMatteo R.P.; Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol  2013,20(3),946-955","journal-title":"Ann Surg Oncol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/2326-6066.CIR-14-0212","volume":"3","author":"Maker A.V.","year":"2015","unstructured":"Maker A.V.; Ito H.; Mo Q.; Weisenberg E.; Qin L.X.; Turcotte S.; Maithel S.; Shia J.; Blumgart L.; Fong Y.; Jarnagin W.R.; DeMatteo R.P.; D\u2019Angelica M.I.; Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res  2015,3(4),380-388","journal-title":"Cancer Immunol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e121932","DOI":"10.1172\/jci.insight.121932","volume":"3","author":"Lazarus J.","year":"2018","unstructured":"Lazarus J.; Maj T.; Smith J.J.; Perusina Lanfranca M.; Rao A.; D\u2019Angelica M.I.; Delrosario L.; Girgis A.; Schukow C.; Shia J.; Kryczek I.; Shi J.; Wasserman I.; Crawford H.; Nathan H.; Pasca Di Magliano M.; Zou W.; Frankel T.L.; Spatial and phenotypic immune profiling of metastatic colon cancer. JCI Insight  2018,3(22),e121932","journal-title":"JCI Insight"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(03)00155-7","volume":"112","author":"Yajnik V.","year":"2003","unstructured":"Yajnik V.; Paulding C.; Sordella R.; McClatchey A.I.; Saito M.; Wahrer D.C.R.; Reynolds P.; Bell D.W.; Lake R.; van den Heuvel S.; Settleman J.; Haber D.A.; DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell  2003,112(5),673-684","journal-title":"Cell"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"740452","DOI":"10.3389\/fonc.2021.740452","volume":"11","author":"Mei Y.","year":"2021","unstructured":"Mei Y.; Li K.; Zhang Z.; Li M.; Yang H.; Wang H.; Huang X.; Li X.; Shi S.; Yang H.; miR-33b-3p acts as a tumor suppressor by targeting DOCK4 in prostate cancer. Front Oncol  2021,11,740452","journal-title":"Front Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/onc.2017.323","volume":"37","author":"Debruyne D.N.","year":"2018","unstructured":"Debruyne D.N.; Turchi L.; Burel-Vandenbos F.; Fareh M.; Almairac F.; Virolle V.; Figarella-Branger D.; Baeza-Kallee N.; Lagadec P.; kubiniek V.; Paquis P.; Fontaine D.; Junier M-P.; Chneiweiss H.; Virolle T.; DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression. Oncogene  2018,37(2),241-254","journal-title":"Oncogene"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.3390\/cancers12113366","volume":"12","author":"Aladowicz E.","year":"2020","unstructured":"Aladowicz E.; Granieri L.; Marocchi F.; Punzi S.; Giardina G.; Ferrucci P.F.; Mazzarol G.; Capra M.; Viale G.; Confalonieri S.; Gandini S.; Lotti F.; Lanfrancone L.; Shc D.; ShcD binds DOCK4, promotes ameboid motility and metastasis dissemination, predicting poor prognosis in melanoma. Cancers (Basel)  2020,12(11),3366","journal-title":"Cancers (Basel)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6629842","volume":"2021","author":"Zhao Q.","year":"2021","unstructured":"Zhao Q.; Zhong J.; Lu P.; Feng X.; Han Y.; Ling C.; Guo W.; Zhou W.; Yu F.; Li J.; DOCK4 is a platinum-chemosensitive and prognostic-related biomarker in ovarian cancer. PPAR Res  2021,2021,1-12","journal-title":"PPAR Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"Li T.","year":"2017","unstructured":"Li T.; Fan J.; Wang B.; Traugh N.; Chen Q.; Liu J.S.; Li B.; Liu X.S.; TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res  2017,77(21),e108-e110","journal-title":"Cancer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Tang Z.","year":"2017","unstructured":"Tang Z.; Li C.; Kang B.; Gao G.; Li C.; Zhang Z.; GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res  2017,45(W1),W98-W102","journal-title":"Nucleic Acids Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","volume":"2","author":"Mizuno H.","year":"2009","unstructured":"Mizuno H.; Kitada K.; Nakai K.; Sarai A.; PrognoScan: A new database for meta-analysis of the prognostic value of genes. BMC Med Genomics  2009,2(1),18","journal-title":"BMC Med Genomics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"Vasaikar S.V.","year":"2018","unstructured":"Vasaikar S.V.; Straub P.; Wang J.; Zhang B.; LinkedOmics: Analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res  2018,46(D1),D956-D963","journal-title":"Nucleic Acids Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"Ru B.","year":"2019","unstructured":"Ru B.; Wong C.N.; Tong Y.; Zhong J.Y.; Zhong S.S.W.; Wu W.C.; Chu K.C.; Wong C.Y.; Lau C.Y.; Chen I.; Chan N.W.; Zhang J.; Wren J.; TISIDB: An integrated repository portal for tumor\u2013immune system interactions. Bioinformatics  2019,35(20),4200-4202","journal-title":"Bioinformatics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e0143777","DOI":"10.1371\/journal.pone.0143777","volume":"10","author":"Wu Y.","year":"2015","unstructured":"Wu Y.; Zhou J.; Li Y.; Zhou Y.; Cui Y.; Yang G.; Hong Y.; Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling. PLoS One  2015,10(11),e0143777","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0029-1242458","volume":"22","author":"Haggar F.","year":"2009","unstructured":"Haggar F.; Boushey R.; Colorectal cancer epidemiology: Incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg  2009,22(4),191-197","journal-title":"Clin Colon Rectal Surg"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jnci\/djh275","volume":"96","author":"O\u2019Connell J.B.","year":"2004","unstructured":"O\u2019Connell J.B.; Maggard M.A.; Ko C.Y.; Colon cancer survival rates with the new American joint committee on Cancer J Natl Cancer Inst  2004,96(19),1420-1425","journal-title":"J Natl Cancer Inst"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1053\/j.gastro.2018.08.009","volume":"155","author":"Mahajan U.M.","year":"2018","unstructured":"Mahajan U.M.; Langhoff E.; Goni E.; Costello E.; Greenhalf W.; Halloran C.; Ormanns S.; Kruger S.; Boeck S.; Ribback S.; Beyer G.; Dombroswki F.; Weiss F.U.; Neoptolemos J.P.; Werner J.; D\u2019Haese J.G.; Bazhin A.; Peterhansl J.; Pichlmeier S.; B\u00fcchler M.W.; Kleeff J.; Ganeh P.; Sendler M.; Palmer D.H.; Kohlmann T.; Rad R.; Regel I.; Lerch M.M.; Mayerle J.; Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma. Gastroenterology  2018,155(5),1625-1639.e2","journal-title":"Gastroenterology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"954992","DOI":"10.3389\/fimmu.2022.954992","volume":"13","author":"Bilotta M.T.","year":"2022","unstructured":"Bilotta M.T.; Antignani A.; Fitzgerald D.J.; Managing the TME to improve the efficacy of cancer therapy. Front Immunol  2022,13,954992","journal-title":"Front Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"gov053","DOI":"10.1093\/gastro\/gov053","volume":"3","author":"Singh P.P.","year":"2015","unstructured":"Singh P.P.; Sharma P.K.; Krishnan G.; Lockhart A.C.; Immune checkpoints and immunotherapy for colorectal cancer. Gastroenterol Rep (Oxf)  2015,3(4),gov053","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.21037\/jgo.2018.01.17","volume":"9","author":"Kalyan A.","year":"2018","unstructured":"Kalyan A.; Kircher S.; Shah H.; Mulcahy M.; Benson A.; Updates on immunotherapy for colorectal cancer. J Gastrointest Oncol  2018,9(1),160-169","journal-title":"J Gastrointest Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/path.5894","volume":"257","author":"Glaire M.A.","year":"2022","unstructured":"Glaire M.A.; Ryan N.A.J.; Ijsselsteijn M.E.; Kedzierska K.; Obolenski S.; Ali R.; Crosbie E.J.; Bosse T.; Miranda N.F.C.C.; Church D.N.; Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. J Pathol  2022,257(3),340-351","journal-title":"J Pathol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/intimm\/dxz067","volume":"32","author":"Kunimura K.","year":"2020","unstructured":"Kunimura K.; Uruno T.; Fukui Y.; DOCK family proteins: Key players in immune surveillance mechanisms. Int Immunol  2020,32(1),5-15","journal-title":"Int Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2147\/CMAR.S190963","volume":"11","author":"Ge W.","year":"2019","unstructured":"Ge W.; Cai W.; Bai R.; Hu W.; Wu D.; Zheng S.; Hu H.; A novel 4-gene prognostic signature for hypermutated colorectal cancer. Cancer Manag Res  2019,11,1985-1996","journal-title":"Cancer Manag Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/gutjnl-2013-306620","volume":"64","author":"Yu J.","year":"2015","unstructured":"Yu J.; Wu W.K.K.; Li X.; He J.; Li X.X.; Ng S.S.M.; Yu C.; Gao Z.; Yang J.; Li M.; Wang Q.; Liang Q.; Pan Y.; Tong J.H.; To K.F.; Wong N.; Zhang N.; Chen J.; Lu Y.; Lai P.B.S.; Chan F.K.L.; Li Y.; Kung H.F.; Yang H.; Wang J.; Sung J.J.Y.; Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut  2015,64(4),636-645","journal-title":"Gut"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1101\/gad.248963.114","volume":"29","author":"Yu J.R.","year":"2015","unstructured":"Yu J.R.; Tai Y.; Jin Y.; Hammell M.C.; Wilkinson J.E.; Roe J.S.; Vakoc C.R.; Van Aelst L.; TGF-\u03b2\/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis. Genes Dev  2015,29(3),250-261","journal-title":"Genes Dev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/path.5197","volume":"247","author":"Westbrook J.A.","year":"2019","unstructured":"Westbrook J.A.; Wood S.L.; Cairns D.A.; McMahon K.; Gahlaut R.; Thygesen H.; Shires M.; Roberts S.; Marshall H.; Oliva M.R.; Dunning M.J.; Hanby A.M.; Selby P.J.; Speirs V.; Mavria G.; Coleman R.E.; Brown J.E.; Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. J Pathol  2019,247(3),381-391","journal-title":"J Pathol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1016\/j.yexcr.2006.09.006","volume":"312","author":"Hiramoto K.","year":"2006","unstructured":"Hiramoto K.; Negishi M.; Katoh H.; Dock4 is regulated by RhoG and promotes Rac-dependent cell migration. Exp Cell Res  2006,312(20),4205-4216","journal-title":"Exp Cell Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"23202","DOI":"10.1002\/jcp.28887","volume":"234","author":"Wang Y.Y.","year":"2019","unstructured":"Wang Y.Y.; Yan L.; Yang S.; Xu H.N.; Chen T.T.; Dong Z.Y.; Chen S.L.; Wang W.R.; Yang Q.L.; Chen C.J.; Long noncoding RNA AC073284.4 suppresses epithelial\u2013mesenchymal transition by sponging miR\u201018b\u20105p in paclitaxel\u2010resistant breast cancer cells. J Cell Physiol  2019,234(12),23202-23215","journal-title":"J Cell Physiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"Steidl C.","year":"2010","unstructured":"Steidl C.; Lee T.; Shah S.P.; Farinha P.; Han G.; Nayar T.; Delaney A.; Jones S.J.; Iqbal J.; Weisenburger D.D.; Bast M.A.; Rosenwald A.; Muller-Hermelink H.K.; Rimsza L.M.; Campo E.; Delabie J.; Braziel R.M.; Cook J.R.; Tubbs R.R.; Jaffe E.S.; Lenz G.; Connors J.M.; Staudt L.M.; Chan W.C.; Gascoyne R.D.; Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N Engl J Med  2010,362(10),875-885","journal-title":"N Engl J Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","volume":"27","author":"Nishikawa H.","year":"2014","unstructured":"Nishikawa H.; Sakaguchi S.; Regulatory T cells in cancer immunotherapy. Curr Opin Immunol  2014,27,1-7","journal-title":"Curr Opin Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e1106677","DOI":"10.1080\/2162402X.2015.1106677","volume":"5","author":"Koelzer V.H.","year":"2016","unstructured":"Koelzer V.H.; Canonica K.; Dawson H.; Sokol L.; Karamitopoulou-Diamantis E.; Lugli A.; Zlobec I.; Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome. OncoImmunology  2016,5(4),e1106677","journal-title":"OncoImmunology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/j.gastro.2009.06.053","volume":"137","author":"Sinicrope F.A.","year":"2009","unstructured":"Sinicrope F.A.; Rego R.L.; Ansell S.M.; Knutson K.L.; Foster N.R.; Sargent D.J.; Intraepithelial effector (CD3+)\/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology  2009,137(4),1270-1279","journal-title":"Gastroenterology"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neo.2019.07.006","volume":"21","author":"Fiegle E.","year":"2019","unstructured":"Fiegle E.; Doleschel D.; Koletnik S.; Rix A.; Weiskirchen R.; Borkham-Kamphorst E.; Kiessling F.; Lederle W.; Dual CTLA-4 and PD-L1 blockade inhibits tumor growth and liver metastasis in a highly aggressive orthotopic mouse model of colon cancer. Neoplasia  2019,21(9),932-944","journal-title":"Neoplasia"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3389\/fimmu.2018.02265","volume":"9","author":"van Willigen W.W.","year":"2018","unstructured":"van Willigen W.W.; Bloemendal M.; Gerritsen W.R.; Schreibelt G.; de Vries I.J.M.; Bol K.F.; Dendritic cell cancer therapy: Vaccinating the right patient at the right time. Front Immunol  2018,9,2265","journal-title":"Front Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"Llosa N.J.","year":"2015","unstructured":"Llosa N.J.; Cruise M.; Tam A.; Wicks E.C.; Hechenbleikner E.M.; Taube J.M.; Blosser R.L.; Fan H.; Wang H.; Luber B.S.; Zhang M.; Papadopoulos N.; Kinzler K.W.; Vogelstein B.; Sears C.L.; Anders R.A.; Pardoll D.M.; Housseau F.; The vigorous immune micro-environment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov  2015,5(1),43-51","journal-title":"Cancer Discov"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","volume":"30","author":"Azimi F.","year":"2012","unstructured":"Azimi F.; Scolyer R.A.; Rumcheva P.; Moncrieff M.; Murali R.; McCarthy S.W.; Saw R.P.; Thompson J.F.; Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol  2012,30(21),2678-2683","journal-title":"J Clin Oncol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jb\/mvg180","volume":"134","author":"Hattori M.","year":"2003","unstructured":"Hattori M.; Minato N.; Rap1 GTPase: Functions, regulation, and malignancy. J Biochem  2003,134(4),479-484","journal-title":"J Biochem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"Crosas-Molist E.","year":"2022","unstructured":"Crosas-Molist E.; Samain R.; Kohlhammer L.; Orgaz J.L.; George S.L.; Maiques O.; Barcelo J.; Sanz-Moreno V.; Rho GTPase signaling in cancer progression and dissemination. Physiol Rev  2022,102(1),455-510","journal-title":"Physiol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fncel.2019.00577","volume":"13","author":"Huang M.","year":"2020","unstructured":"Huang M.; Liang C.; Li S.; Zhang J.; Guo D.; Zhao B.; Liu Y.; Peng Y.; Xu J.; Liu W.; Guo G.; Shi L.; Two Autism\/Dyslexia Linked Variations of DOCK4 Disrupt the Gene Function on Rac1\/Rap1 Activation, Neurite Outgrowth, and Synapse Development. Front Cell Neurosci  2020,13,577","journal-title":"Front Cell Neurosci"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230912094101","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220933\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230912094101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:28:12Z","timestamp":1716380892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220933\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207326666230912094101","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}